Archive for November 2013

ModiQuest Research Extends its Product Offering with Monoclonal Human Anti-Modified Citrulline (AMC) Antibody

Place your order in 2013 and get a 30% price discount! November 11, 2013 – Oss, The Netherlands. ModiQuest Research BV, the Dutch antibody generation services and development company, today announced that it has expanded its product offering with a monoclonal human anti-modified citrulline (AMC) antibody. This AMC antibody is developed for the detection of … Continue reading

ModiQuest Research and Dako to Expand Antibody Generation Collaboration

November 5, 2013 – Oss, The Netherlands. ModiQuest Research BV, the Dutch antibody generation services company, today announced that it has expanded its research collaboration with Dako – an Agilent Technologies company.  After the successful generation of monoclonal antibodies by ModiQuest against a proprietary target selected by Dako earlier this year, both parties have extended … Continue reading

ModiQuest at the European Antibody Congress in Geneva, November 11-13, 2013

Looking to for a partner to outsource some of your custom antibody generation and development activities?  Pass by our booth at the event and talk to us about your antibody needs!  Or call us on +31 412 846 000 to fix a time to talk! About ModiQuest Research: ModiQuest specializes in the generation of monoclonal … Continue reading

ModiQuest at the PEGS in Lisbon – November 4 – 8, 2013

Is your in-house capacity to generate antibodies running short?  Or are you looking for additional outsourcing options for generating antibodies against priority or difficult target antigens?  Pass by our booth at the event and talk to us about your antibody needs!  Or call us on +31 412 846 000 to fix a time to talk! About … Continue reading

ModiQuest Research and Beckman Research Institute of the City of Hope Enter in Antibody Generation Collaboration

October 30, 2013 – Oss, The Netherlands.  ModiQuest Research BV, the Dutch antibody generation services company, today announced that it has entered into a research collaboration with the Beckman Research Institute of the City of Hope (“BRICOH”) aimed at the generation of novel monoclonal antibodies against a target selected by and proprietary to BRICOH.  During … Continue reading

shopping basket 0 items

Shopping Cart

0

Your shopping cart is empty:

please visit the shop